Company logo
Go back

 

US FDA authorizes marketing of IQOS as a Modified Risk Tobacco Product

The U.S. Food and Drug Administration (FDA) yesterday authorized the marketing of IQOS, Philip Morris International’s (PMI) electrically heated tobacco system, as a modified risk tobacco product (MRTP). In doing so, the US FDA found that an IQOS exposure modification order is appropriate to promote the public health.

Link: Punto.com